|
|
|
|
pmid:26718448
|
|
|
|
|
pmid:25908532
|
|
|
|
|
pmid:25890752
|
|
|
|
|
pmid:24929111
|
|
|
|
|
pmid:27573422
|
|
|
|
|
pmid:26638987
|
|
|
|
|
pmid:26630551
|
|
|
|
|
pmid:29095817
|
|
|
|
|
pmid:27559094
|
|
|
|
|
pmid:26597784
|
|
|
|
|
pmid:27508346
|
|
|
|
|
pmid:25806690
|
|
|
|
|
pmid:24784707
|
|
|
|
|
pmid:28779028
|
|
|
|
|
pmid:26550951
|
|
|
|
|
pmid:28694292
|
|
|
|
|
pmid:28610917
|
|
|
|
|
pmid:28584076
|
|
|
|
|
pmid:26531230
|
|
|
|
|
pmid:27362771
|
|
|
|
|
pmid:26492476
|
|
|
|
|
pmid:28442547
|
|
|
|
|
pmid:27317426
|
|
|
|
|
pmid:24571866
|
|
|
|
|
pmid:24451959
|
|
|
|
|
pmid:28322829
|
|
|
|
|
pmid:26335632
|
|
|
|
|
pmid:28237084
|
|
|
|
|
pmid:28218420
|
|
|
|
|
pmid:25453942
|
|
|
|
|
pmid:27044027
|
|
|
|
|
pmid:22610993
|
|
|
|
|
pmid:27034112
|
|
|
|
|
pmid:26927755
|
|
|
|
|
pmid:26159746
|
|
|
|
|
pmid:25218162
|
|
|
|
|
pmid:26118631
|
|
|
|
|
pmid:25123641
|
|
|
|
|
pmid:26808633
|
|
|
|
|
pmid:27133431
|
|
|
|
|
pmid:25030943
|
|
|
|
|
pmid:
|
Serhan CN et al. |
Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. |
2004 |
Prostaglandins Other Lipid Mediat. |
pmid:15290791
|
Weylandt KH et al. |
Lipoxins and resolvins in inflammatory bowel disease. |
2007 |
Inflamm. Bowel Dis. |
pmid:17262807
|
Sun YP et al. |
Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. |
2007 |
J. Biol. Chem. |
pmid:17244615
|
Haworth O and Levy BD |
Endogenous lipid mediators in the resolution of airway inflammation. |
2007 |
Eur. Respir. J. |
pmid:17978156
|
Hong S et al. |
Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. |
2007 |
J. Am. Soc. Mass Spectrom. |
pmid:17055291
|
Ariel A and Serhan CN |
Resolvins and protectins in the termination program of acute inflammation. |
2007 |
Trends Immunol. |
pmid:17337246
|
Chen Y et al. |
Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. |
2008 |
Med. Hypotheses |
pmid:18448265
|
Serhan CN |
Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. |
2008 |
J. Periodontol. |
pmid:18673006
|
Merched AJ et al. |
Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. |
2008 |
FASEB J. |
pmid:18559988
|
Kasuga K et al. |
Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. |
2008 |
J. Immunol. |
pmid:19050288
|
Wendel M and Heller AR |
Anticancer actions of omega-3 fatty acids--current state and future perspectives. |
2009 |
Anticancer Agents Med Chem |
pmid:19442044
|
Tian H et al. |
Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. |
2009 |
Invest. Ophthalmol. Vis. Sci. |
pmid:19443724
|
Jin Y et al. |
Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. |
2009 |
Invest. Ophthalmol. Vis. Sci. |
pmid:19407006
|
Spite M et al. |
Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. |
2009 |
Br. J. Pharmacol. |
pmid:19422383
|
Kaarniranta K and Salminen A |
NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). |
2009 |
Exp. Gerontol. |
pmid:19751815
|
Filep JG |
Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. |
2009 |
Br. J. Pharmacol. |
pmid:19845687
|
Sommer C and Birklein F |
Fighting off pain with resolvins. |
2010 |
Nat. Med. |
pmid:20448572
|
Krishnamoorthy S et al. |
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. |
2010 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:20080636
|
Yuan J et al. |
The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. |
2010 |
Prostaglandins Other Lipid Mediat. |
pmid:20394833
|
Xu ZZ et al. |
Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. |
2010 |
Nat. Med. |
pmid:20383154
|
Bang S et al. |
Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. |
2010 |
Br. J. Pharmacol. |
pmid:20880407
|
Marcheselli VL et al. |
Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. |
2010 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:19931440
|
Levy BD |
Resolvins and protectins: natural pharmacophores for resolution biology. |
2010 Apr-Jun |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:20227865
|
Titos E et al. |
Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. |
2011 |
J. Immunol. |
pmid:22013115
|
Palmer CD et al. |
17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. |
2011 |
J. Leukoc. Biol. |
pmid:21653234
|
Fredman G and Serhan CN |
Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. |
2011 |
Biochem. J. |
pmid:21711247
|
Park CK et al. |
Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. |
2011 |
J. Neurosci. |
pmid:22171045
|
Hellmann J et al. |
Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. |
2011 |
FASEB J. |
pmid:21478260
|
Norling LV et al. |
Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. |
2011 |
J. Immunol. |
pmid:21460209
|
Wang B et al. |
Resolvin D1 protects mice from LPS-induced acute lung injury. |
2011 |
Pulm Pharmacol Ther |
pmid:21501693
|
Bento AF et al. |
Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. |
2011 |
J. Immunol. |
pmid:21724996
|
Recchiuti A et al. |
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. |
2011 |
FASEB J. |
pmid:20956612
|
Schif-Zuck S et al. |
Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. |
2011 |
Eur. J. Immunol. |
pmid:21268007
|
Huang L et al. |
Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. |
2011 |
Pain |
pmid:21255928
|
Lima-Garcia JF et al. |
The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. |
2011 |
Br. J. Pharmacol. |
pmid:21418187
|
Dartt DA et al. |
Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. |
2011 |
J. Immunol. |
pmid:21357260
|
Ji RR et al. |
Emerging roles of resolvins in the resolution of inflammation and pain. |
2011 |
Trends Neurosci. |
pmid:21963090
|
Clà ria J et al. |
Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. |
2012 |
J. Immunol. |
pmid:22844113
|
Quan-Xin F et al. |
Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. |
2012 |
BMC Gastroenterol |
pmid:23092159
|
Mas E et al. |
Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. |
2012 |
Clin. Chem. |
pmid:22912397
|
Martin N et al. |
Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. |
2012 |
PLoS ONE |
pmid:22970103
|
Dalli J and Serhan CN |
Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. |
2012 |
Blood |
pmid:22904297
|
Odusanwo O et al. |
Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. |
2012 |
Am. J. Physiol., Cell Physiol. |
pmid:22237406
|
Bang S et al. |
17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. |
2012 |
Br. J. Pharmacol. |
pmid:21718307
|
Rogerio AP et al. |
Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. |
2012 |
J. Immunol. |
pmid:22802419
|
Jones CN et al. |
Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. |
2012 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:23185003
|
Norling LV et al. |
Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. |
2012 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:22499990
|
Krishnamoorthy S et al. |
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. |
2012 |
Am. J. Pathol. |
pmid:22449948
|
Liao Z et al. |
Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. |
2012 |
Respir. Res. |
pmid:23199346
|
Chiang N et al. |
Infection regulates pro-resolving mediators that lower antibiotic requirements. |
2012 |
Nature |
pmid:22538616
|
Settimio R et al. |
Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. |
2012 |
Mediators Inflamm. |
pmid:23304060
|
Widgerow AD |
Cellular resolution of inflammation--catabasis. |
2012 Jan-Feb |
Wound Repair Regen |
pmid:22276585
|
Mustafa M et al. |
Resolvin D1 protects periodontal ligament. |
2013 |
Am. J. Physiol., Cell Physiol. |
pmid:23864609
|
Lee HJ et al. |
Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. |
2013 |
Int. J. Biochem. Cell Biol. |
pmid:24120851
|
Abdelmoaty S et al. |
Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. |
2013 |
PLoS ONE |
pmid:24086560
|
Sun YB et al. |
Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. |
2013 |
PLoS ONE |
pmid:24391884
|
Zhang X et al. |
Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. |
2013 |
Oxid Med Cell Longev |
pmid:24381712
|
Wu D et al. |
Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. |
2013 |
Mediators Inflamm. |
pmid:24174713
|